Stephen Saad’s Aspen: From JSE newcomer to R150bn valuation in 16 years
In 1998, Stephen Saad and Gus Attridge took their ambitions public through the reverse takeover by their year-old business into JSE-listed Medhold. A year later
Aspen’s revenue soars by 53% to R29.5 billion
Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), the fifth largest generic company in the world and Africa’s largest pharmaceutical manufacturer, has announced
Honorary Doctor of Commerce Degree conferred on Stephen Saad
[vimeo id=”91664323″ align=”center” aspect_ratio=”16:9″] Port Elizabeth – The Nelson Mandela Metropolitan University (NMMU) today conferred the degree of Doctor of Commerce (honoris causa) on Stephen
Aspen’s half-year revenue increases to R12 billion
Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), the ninth largest generic company in the world and Africa’s largest pharmaceutical manufacturer, has announced
Aspen’s growth formula
On a recent holiday to Disney World with his family, Aspen Pharmacare CE Stephen Saad wandered into a pharmacy while his children enjoyed the rides.
Honouring Former President Nelson Mandela
Johannesburg, Friday 6 December 2013 – Today, as the world mourns the passing of one of its most outstanding citizens and South Africa’s former President,
Transactions
Aspen concludes the acquisition of an API Business from MSD
01 October 2013 By : Shauneen Beukes 1 October 2013 Oss, the Netherlands – JSE Limited listed Aspen Holdings, the ninth largest generic pharmaceutical company
Aspen acquires GSK brands and manufacturing site for £700 million
Durban, South Africa: Aspen Global Incorporated (“AGI”), a wholly owned subsidiary of Aspen, announced today that it will acquire from GlaxoSmithKline plc (“GSK”) the Arixtra
Media Enquiries
Shauneen Beukes
Group Communications Consultant
+27 31 580 8600
+27 82 389 8900
sbeukes@aspenpharma.com
